G. Lakner

Effects of third generation aromatase inhibitors on bone health and other safety parameters: results of an open, randomised, multi-centre study of letrozole, exemestane and anastrozole in healthy postmenopausal women.

R. Eastell, E. McCloskey, W. Fraser, 2007, European journal of cancer.

The letrozole (L), exemestane (E), and anastrozole (A) pharmacodynamics (LEAP) trial: A direct comparison of bone biochemical measurements between aromatase inhibitors (AIs) in healthy postmenopausal women.

R. Eastell, E. McCloskey, G. Clack, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High aortoiliac occlusion: treatment with thoracic aorta to femoral arterial bypass.

L. Lukacs, G. Lakner, 1983, The Journal of cardiovascular surgery.

Gas chromatography nitrogen phosphorous detection (GC-NPD) assay of tofisopam in human plasma for pharmacokinetic evaluation.

I. Klebovich, S. Drabant, B. Varga, 2006, Journal of pharmaceutical and biomedical analysis.

A pilot study of Golexanolone, a new GABA-A receptor modulating steroid antagonist, in patients with covert hepatic encephalopathy.

H. Vilstrup, B. Scharschmidt, M. Schalling, 2021, Journal of hepatology.